Arbutus Biopharma Corporation (FRA:I9DN)
3.796
-0.060 (-1.56%)
At close: Dec 19, 2025
Arbutus Biopharma Market Cap
Arbutus Biopharma has a market cap or net worth of €727.09 million as of December 22, 2025. Its market cap has increased by 8.04% in one year.
Market Cap
727.09M
Enterprise Value
651.06M
Revenue
12.45M
Ranking
n/a
PE Ratio
n/a
Stock Price
€3.80
Market Cap Chart
Since November 15, 2010, Arbutus Biopharma's market cap has increased from 53.50M to 727.09M, an increase of 1,259.03%. That is a compound annual growth rate of 18.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 727.09M | 21.48% |
| Dec 31, 2024 | 598.51M | 57.80% |
| Dec 29, 2023 | 379.28M | 11.19% |
| Dec 30, 2022 | 341.13M | -26.27% |
| Dec 31, 2021 | 462.69M | 87.76% |
| Dec 31, 2020 | 246.42M | 60.15% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 243.17B |
| Siemens Aktiengesellschaft | 183.57B |
| Allianz SE | 146.73B |
| Deutsche Telekom AG | 129.76B |
| Siemens Energy AG | 102.30B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 71.18B |
| Rheinmetall AG | 71.12B |
| Deutsche Bank Aktiengesellschaft | 62.30B |